Management of attention-deficit hyperactivity disorder
Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and communi...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173906/ |
id |
pubmed-3173906 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-31739062011-10-04 Management of attention-deficit hyperactivity disorder Verma, Rohit Balhara, Yatan Pal Singh Mathur, Shachi Review Article Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and community life of 39% of school-going children worldwide. There is increasing recognition that ADHD symptoms and clinically defined disorder can persist into adult life and are associated with later drug and alcohol misuse and social and work difficulties. Added to that is the extreme variability of the disorder over time, within the same individual, between individuals, and across different circumstances. Treatment with stimulants and nonstimulants has proven effective in different subgroups, with the effectiveness of specific agents most likely related to the primary neurotransmitter involved. However, stimulants with a short duration of action have been problematic for some patients. Parent training and cognitive behavioral therapies represent the most widely adjunct psychosocial interventions to pharmacotherapy. Medknow Publications 2011 /pmc/articles/PMC3173906/ /pubmed/21977081 http://dx.doi.org/10.4103/1817-1745.84400 Text en © Journal of Pediatric Neurosciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Verma, Rohit Balhara, Yatan Pal Singh Mathur, Shachi |
spellingShingle |
Verma, Rohit Balhara, Yatan Pal Singh Mathur, Shachi Management of attention-deficit hyperactivity disorder |
author_facet |
Verma, Rohit Balhara, Yatan Pal Singh Mathur, Shachi |
author_sort |
Verma, Rohit |
title |
Management of attention-deficit hyperactivity disorder |
title_short |
Management of attention-deficit hyperactivity disorder |
title_full |
Management of attention-deficit hyperactivity disorder |
title_fullStr |
Management of attention-deficit hyperactivity disorder |
title_full_unstemmed |
Management of attention-deficit hyperactivity disorder |
title_sort |
management of attention-deficit hyperactivity disorder |
description |
Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and community life of 39% of school-going children worldwide. There is increasing recognition that ADHD symptoms and clinically defined disorder can persist into adult life and are associated with later drug and alcohol misuse and social and work difficulties. Added to that is the extreme variability of the disorder over time, within the same individual, between individuals, and across different circumstances. Treatment with stimulants and nonstimulants has proven effective in different subgroups, with the effectiveness of specific agents most likely related to the primary neurotransmitter involved. However, stimulants with a short duration of action have been problematic for some patients. Parent training and cognitive behavioral therapies represent the most widely adjunct psychosocial interventions to pharmacotherapy. |
publisher |
Medknow Publications |
publishDate |
2011 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173906/ |
_version_ |
1611475826672402432 |